Treatment with the immune checkpoint inhibitor nivolumab (Opdivo) yielded durable responses in some patients with advanced non-small cell lung cancer (NSCLC), with a five-year survival rate of 16 percent, according to data ...
Apr 3, 2017
0
1
Patients who experience anxiety and depression after being diagnosed with advanced lung cancer are more likely to die sooner, according to new research from the University of British Columbia and BC Cancer Agency.
Jan 24, 2017
0
0
A new analysis of records in the Veteran's Affairs Central Cancer Registry demonstrates a clear positive impact of the increased use of stereotactic body radiation therapy (SBRT) to treat patients with stage I non-small cell ...
Sep 26, 2016
0
2
Patients with late-stage, non-small cell lung cancer (NSCLC) who have surgery have better survival rates than those who don't, but fewer of these patients are undergoing surgery, UC Davis researchers have found.
Jun 9, 2016
0
2
Patients with operable stage I non-small cell lung cancer (NSCLC) could achieve better overall survival rates if treated with Stereotactic Ablative Radiotherapy (SABR) rather than the current standard of care—invasive surgery—according ...
May 13, 2015
0
11
A clinical trial that combined stereotactic body radiation therapy with a specific chemotherapy regimen more than doubled survival rates for certain stage 4 lung cancer patients, UT Southwestern Medical Center cancer researchers ...
Jan 2, 2015
0
16
The most comprehensive international comparison of cancer survival to date, covering countries that are home to two-thirds of the world's population, shows extremely wide differences in survival between countries.
Nov 26, 2014
0
0
Around 1,800 lung cancer patients may be missing out on life-saving surgery each year, according to the latest regional cancer statistics from Cancer Research UK.
Oct 24, 2014
0
0
The findings suggest that family doctors may not be picking up the signs of lung cancer and investigating them as appropriately as they might, or promptly enough, say the researchers.
Oct 13, 2014
0
0
Findings of a trial of a drug aimed at treating advanced oesophageal - or gullet - cancer could lead to a new treatment approach for a sub-group of patients with this kind of cancer.
Aug 22, 2014
0
0
